Stephan Frangakis

Stephan Frangakis

Auto-generated profile, based on publicly available information

Stephan Frangakis

Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2023 in Anesthesiology
Verified
Journal Article
Open access
PDF file
SFStephan G. Frangakis
Stephan G. Frangakis
MMM.L.I.S. Mark MacEachern
M.L.I.S. Mark MacEachern
TAT. Adam Akbar
T. Adam Akbar
CBChristian Bolton
Christian Bolton
VLVictor Lin
Victor Lin
MBM.D. Mark C. Bicket
M.D. Mark C. Bicket
Background: Postsurgical pain is a key component of surgical recovery. However, the genetic drivers of postsurgical pain remain unclear. A broad review and meta-analyses of variants of interest will help investigators understand the potential effects of genetic variation. Methods: This article is a systematic review of genetic variants associated with postsurgical pain in humans, assessing association with postsurgical pain scores and opioid use in both acute (0 to 48 h postoperatively) and chronic (at least 3 months postoperatively) settings. PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched from 2000 to 2022 for studies using search terms related to genetic variants and postsurgical pain in humans. English-language studies in adult patients examining associations of one or more genetic variants with postsurgical pain were included. The primary outcome was association of genetic variants with either acute or chronic postsurgical pain. Pain was measured by patient-reported pain score or analgesic or opioid consumption. Results: A total of 163 studies were included, evaluating 129 unique genes and 594 unique genetic variants. Many of the reported significant associations fail to be replicated in other studies. Meta-analyses were performed for seven variants for which there was sufficient data (OPRM1 rs1799971; COMT rs4680, rs4818, rs4633, and rs6269; and ABCB1 rs1045642 and rs2032582). Only two variants were associated with small differences in postsurgical pain: OPRM1 rs1799971 (for acute postsurgical opioid use standard mean difference = 0.25; 95% CI, 0.16 to 0.35; cohort size, 8,227; acute postsurgical pain score standard mean difference = 0.20; 95% CI, 0.09 to 0.31; cohort size, 4,619) and COMT rs4680 (chronic postsurgical pain score standard mean difference = 0.26; 95% CI, 0.08 to 0.44; cohort size, 1,726). Conclusions: Despite much published data, only two alleles have a small association with postsurgical pain. Small sample sizes, potential confounding variables, and inconsistent findings underscore the need to examine larger cohorts with consistent outcome measures. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New:

1 November 2011 in Genetics
Verified
Journal Article
Open access
MCMichelle E Casad
Michelle E Casad
DADennis Abraham
Dennis Abraham
IKIl-Man Kim
Il-Man Kim
SFStephan Frangakis
Stephan Frangakis
BDBrian Dong
Brian Dong
HRHoward A Rockman
Howard A Rockman
The Minute syndrome in Drosophila melanogaster is characterized by delayed development, poor fertility, and short slender bristles. Many Minute loci correspond to disruptions of genes for cytoplasmic ribosomal proteins, and therefore the phenotype has been attributed to alterations in translational processes. Although protein translation is crucial for all cells in an organism, it is unclear why Minute mutations cause effects in specific tissues. To determine whether the heart is sensitive to haplo-insufficiency of genes encoding ribosomal proteins, we measured heart function of Minute mutants using optical coherence tomography. We found that cardiomyopathy is associated with the Minute syndrome caused by haplo-insufficiency of genes encoding cytoplasmic ribosomal proteins. While mutations of genes encoding non-Minute cytoplasmic ribosomal proteins are homozygous lethal, heterozygous deficiencies spanning these non-Minute genes did not cause a change in cardiac function. Deficiencies of genes for non-Minute mitochondrial ribosomal proteins also did not show abnormal cardiac function, with the exception of a heterozygous disruption of mRpS33. We demonstrate that cardiomyopathy is a common trait of the Minute syndrome caused by haplo-insufficiency of genes encoding cytoplasmic ribosomal proteins. In contrast, most cases of heterozygous deficiencies of genes encoding non-Minute ribosomal proteins have normal heart function in adult Drosophila.

11 September 2024 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
SRSama Ramo
Sama Ramo
SFStephan Frangakis
Stephan Frangakis
JWJennifer F Waljee
Jennifer F Waljee
MBMark C Bicket
Mark C Bicket
Despite a decline in opioid prescriptions over the past decade, patients commonly receive opioid analgesics as a treatment for postoperative pain in the USA. One complication that patients may experience after surgery is persistent postoperative opioid use (PPOU), or opioid use beyond the typical recovery period. Often defined as beyond 3 months postsurgery, PPOU is frequently conflated with chronic postsurgical pain (CPSP), where pain persists well after the expected healing time following surgery. This narrative review explores the distinct risk factors for each condition, their interrelation, and potential future research directions. For PPOU, major risk factors include the risky use of substances including misuse and use disorders; depression and other mental health disorders; a history of chronic pain before surgery including back pain; and certain surgical types (ie, total knee arthropathy, open cholecystectomy, total hip arthropathy). Conversely, CPSP risk factors include the type of surgery (ie, thoracic and breast surgeries), mental health conditions (particularly catastrophizing), and pain in both the preoperative and postoperative phases. Despite the overlap of some factors, studies typically employ different frameworks when examining PPOU and CPSP, with a biopsychosocial model applied for CPSP and little emphasis on an individual’s social environment employed for PPOU. Additionally, existing studies predominantly rely on retrospective insurance claims data, which may not capture the full scope of risk factors. To fill gaps in understanding, investigations may prospectively assess and analyze patient-reported outcomes, implement similar frameworks, and concurrently measure both conditions to advance the scientific understanding of PPOU and CPSP.

26 June 2026 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Open access
SFStephan Frangakis
Stephan Frangakis
SKScott J Keating
Scott J Keating
KPKonrad Pisarczyk
Konrad Pisarczyk
JTJan Tuzil
Jan Tuzil
AMAnn M Menzie
Ann M Menzie
Background: New persistent opioid use (NPOU) after surgery is a serious surgical complication associated with increased risk of opioid abuse, mortality, morbidity, and greater healthcare resource utilization. Objective: This meta-analysis aimed to estimate the pooled incidence of NPOU following surgery in the USA and examine its association with selected risk factors, patient characteristics, and study characteristics. Evidence review: PubMed and Embase were searched on March 1, 2024, to identify observational studies published between January 1, 2013, and March 1, 2024, that reported the incidence of NPOU among adult patients newly prescribed opioids for postsurgical pain. Study quality was assessed using the Newcastle-Ottawa Scale for cohort studies. Pooled incidence estimates of NPOU were generated using random-effects models overall and within subgroups stratified by surgery type, payer coverage, exclusion of subsequent analgesia/surgery, and NPOU definitions. Meta-regression analyses were conducted to explore associations between NPOU and select patient attributes. The protocol was registered in PROSPERO (CRD42023446403). Findings: A total of 43 observational studies (n=6 507 173 participants) were included in the meta-analysis; 8 (18.60%) were rated as low quality, 31 (72.09%) as moderate quality, and 4 (9.30%) as high quality. The pooled incidence of NPOU was estimated to be 7.15% (95% CI 6.02 to 8.38), with high heterogeneity (I 2 =100%) and a 95% prediction interval of 1.34% to 17.02%. Metaregression analyses indicated that the pooled estimate was not significantly associated with study sample size, racial distribution, proportion of male patients, or mean age. Estimates of NPOU did not differ significantly by surgery type (p=0.4912), payer coverage (p=0.0697), or subsequent analgesia/surgery (p=0.6335). However, incidence estimates were significantly higher in the 35 studies defining NPOU as opioid use within 90–180 days after surgery (8.29%, p<0.0001) compared with eight studies applying a more stringent definition of NPOU requiring evidence of opioid use over a 180-day postoperative period (2.89%). Conclusions: This large meta-analysis indicates that NPOU is a common but highly variable outcome among opioid-naive surgical patients in the USA who are prescribed opioids for acute pain. Given the high volume of surgeries performed annually, these findings suggest millions of patients may be at risk for persistent opioid use and related adverse outcomes. However, results should be interpreted cautiously, given the substantial between-study heterogeneity and the inherent limitations of the observational studies included. These findings highlight an urgent need for effective non-opioid pain management strategies and policies to improve access to safer alternatives.

17 October 2025 in Science Advances
Verified
Journal Article
Open access
KKKamal Khan
Kamal Khan
ETErika Tavares
Erika Tavares
KBKatherine Bishara
Katherine Bishara
AOAysegul Ozanturk
Aysegul Ozanturk
LQLeila Qebibo
Leila Qebibo
EDErica Davis
Erica Davis
Dysfunction at the centrosome-cilium interface underlies a broad range of ciliopathies. Here, we identify biallelic variants in CEP76 , encoding a centrosomal protein, in eight unrelated individuals presenting with neurodevelopmental, ocular, and variable additional multisystem features. Proband-derived fibroblasts and CEP76-depleted RPE1 cells display ciliary deficits, including impaired cilium formation and length, disrupted transition zone architecture, and impaired IFT88-mediated anterograde intraflagellar transport. Zebrafish cep76 mutants recapitulate key clinical phenotypes, and in vitro complementation assays confirm pathogenicity for all tested human disease-associated variants. Proteomics analysis identifies CEP76 interactors, including known partners CCP110 and CEP97, and highlights clinically and functionally relevant candidates, including ALMS1 and LUZP1. Together, these findings expand the role of CEP76 beyond centriole duplication to include ciliary assembly and trafficking, establishing it as a ciliopathy gene. This work provides mechanistic insights into CEP76 -related disease and broadens our understanding of centrosome-cilium biology.

3 April 2026 in Anesthesiology
Verified
Journal Article
Closed access
SFStephan G. Frangakis
Stephan G. Frangakis
XMXuran Meng
Xuran Meng
MBMark C. Bicket
Mark C. Bicket
VGVidhya Gunaseelan
Vidhya Gunaseelan
SASawsan As-Sanie
Sawsan As-Sanie
CBChad M. Brummett
Chad M. Brummett
Background: A substantial proportion of patients report no pain after surgery, resulting in an excess of zero values that pose challenges for analysis using traditional statistical models. The current study was designed to test the hypothesis that a two-part model, commonly used in healthcare expenditures research, would demonstrate superior performance in predicting postsurgical pain when compared with traditional models and would secondarily better identify predictors of this clinically important outcome. Methods: This study analyzed a prospectively collected single-center data set (n = 3,925) of chronic postsurgical pain to compare a novel two-part modeling framework with logistic and linear regression. The two-part model first estimated the probability of experiencing postsurgical pain at 3 months (binary outcome), followed by the severity of pain among those affected (on a 1 to 10 numeric rating scale). To obtain an unbiased assessment of model performance, the data were randomly split into training (n = 3,000) and testing (n = 925) data sets. The models were trained on the training data set and evaluated on the testing set. This process was repeated 400 times to compute average performance estimates. As a secondary aim, the study assessed the associations of 15 baseline factors, including validated measures of patient-reported pain, functional and psychological measures, comorbidities, and surgical details, across the different modeling approaches. Results: The two-part model demonstrated superior predictive performance compared with linear regression alone, with a higher mean R 2 value (0.075 vs . 0.050; P < 0.0001), lower root mean square error (1.466 vs . 1.485; P < 0.0001), and lower mean absolute error (1.020 vs . 1.030; P < 0.0001). Statistical comparison with logistic regression alone was not possible due to the shared binary component. The two-part model identified seven baseline preoperative covariates as independently associated with postsurgical pain that were missed by either logistic or linear models or both: self-reported race, education level, American Society of Anesthesiologists classification, overall body pain, widespread pain, symptom severity, and anxiety level. Significant baseline factors identified in all three models were patient sex, surgical type, and surgical site pain. Conclusions: A two-part model may offer a superior statistical approach to linear and logistic regression, better identifying patient- and clinical care–related risk factors of chronic postsurgical pain, primarily by distinguishing factors that drive the occurrence of chronic pain from those that are associated with pain severity.